Simplify Logo
Prolaio

Prolaio

Real-time cardiovascular care analytics platform

Data Science Intern

Summer 2026Posted on 2/17/2026
$50/hr
Internship
Master's
Chicago, IL, USA
In Person

Relocation or housing stipends are not offered for this internship.

About the job

Requirements
  • Currently enrolled in a Master’s or graduate-level program in Computer Science, Data Science, Biomedical Informatics, Bioengineering, Computational Biology, or a related field.
  • Strong proficiency in Python programming with experience using Large Language Model APIs.
  • Familiarity with Natural Language Processing concepts, specifically Prompt Engineering.
  • Experience handling unstructured text data, cleaning messy real-world data, and/or working with human evaluation datasets.
  • Analytical Skills: Ability to handle edge cases in text (e.g., negation) and validate one’s own output using standard validation metrics.
Responsibilities
  • Endpoint Extraction Pipeline Development: Develop Python/LLM workflows, including workflows built on purpose-built clinical extraction tools, to ingest unstructured data (clinical notes, discharge summaries) and extract key study endpoints, specifically Clinical Events or “Unified Problem Lists”
  • Validation Framework Execution: Design and conduct a human review validation study comparing LLM-generated abstractions against a “gold standard” dataset derived from manual chart review.
  • Codebase Delivery: Build and maintain a documented code repository that inputs raw EHR data and outputs structured clinical datasets for study data.
  • Performance Analysis & Reporting: Analyze pipeline performance to establish concordance, sensitivity, and specificity metrics, delivering a final validation report with performance metric for multiple approaches.
  • Cross-Functional Collaboration: Collaborate with clinical and technical mentors to translate clinical requirements into technical solutions.

About the company

Prolaio provides a cardiovascular-focused health tech platform that helps healthcare providers improve patient outcomes through real-time data analytics and continuous monitoring. It collects data from electronic health records, patient surveys, and wearable sensors to build predictive models that warn care teams about potential health issues before they become critical. Healthcare providers access the platform via a subscription, giving them real-time analytics, alerts, and evidence-based care planning tools to monitor patients and optimize treatments. The company differentiates itself by concentrating on cardiovascular care and enabling continuous learning, patient engagement, and collaboration with pharmaceutical companies and research institutions to support new therapies. The overall goal is to reduce hospital admissions and readmissions while delivering timely, data-driven care that keeps patients healthier.

Company Size

51-200

Company Stage

Early VC

Total Funding

$25.5M

Headquarters

Scottsdale, Arizona

Founded

2022

Get referred to Prolaio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Kardigan’s June 2026 IPO raised $422.4 million, extending runway and platform investment.
  • OCORO Heart Study launched in 2026, expanding Prolaio’s remote data capture footprint.
  • Kardigan’s Q2 2026 update says Prolaio supports three late-stage programs and trial optimization.

What critics are saying

  • Kardigan now owns Prolaio; pipeline failures starve the platform by 2027.
  • Contingent milestone liabilities hit $47.3 million by June 30, 2026, pressuring economics.
  • Cardiovascular data regulation and privacy breaches can trigger FDA scrutiny and customer churn.

What makes Prolaio unique

  • FDA-cleared algorithms and 20-plus patents underpin Prolaio’s cardiovascular intelligence moat.
  • Prolaio spans 26 countries and four million patient-hours of curated CV data.
  • Kardigan still offers Prolaio industry-wide, not just inside its own trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Stock Options

Company Equity

Retirement Plan: 401(k) plan

Paid Time Off

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-1%
Business Wire
Mar 28th, 2025
Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform

Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announced today that it has acquired Prolaio, a clinical intelligence comp...

U.S. Securities and Exchange Commission
Sep 13th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

INACTIVE